point-of-care testing

(redirected from Point-of-Care Test)

point-of-care testing

Lab medicine The analysis of clinical specimens as close as possible to the Pt, including bedside, ward–unit, or 'stat' regional response labs that service specified areas–eg, the ER or ICU

point-of-care testing

,

POCT

A clinical laboratory measurement made at the bedside, in the clinic, or in a satellite lab, rather than at a centralized laboratory. POCT is designed to improve the turnaround time and usefulness of lab testing. Examples of POCT are nitrazine strips for measuring vaginal pH, refractometers for measuring urine specific gravity, glucometers for measuring blood sugar, and immunoassays for measuring the creatine phosphokinase isoenzymes, myoglobin, and troponin I.
References in periodicals archive ?
A Burnet Institute point-of-care test for the early detection of sepsis is one of 13 pioneering medical research projects to benefit from the inaugural round of the Victorian Medical Research Fund.
A point-of-care test using oral fluid for HIV diagnosis is very user-friendly, as giving oral samples is less invasive for the patient and sample collection has less biosafety hazards for the collector of sample.
If patients did not want the confirmatory testing (which requires venipuncture) and would not otherwise undergo routine blood tests as part of their regular medical care, they would still be offered the point-of-care test.
19 July 2013 - US point-of-care test developer TB Biosciences Inc said yesterday it had raised USD 1.
Tokyo, Japan, May 19, 2006 - (JCN) - Shionogi has concluded a sales agreement with Canadian company Response Medical for the sale of SHIONOSPOT BNP, a point-of-care test reagent, and the SHIONOSPOT Reader in Japan.
Studies have shown that this point-of-care test can help diabetic outpatients to stabilize glucose levels and to decrease the risk of diabetes complications.
17) The use of unauthorized point-of-care test results in diagnosis and treatment does not comply with practice standards; accreditation requirements; or the security, confidentiality, authentication, integrity, and auditing requirements of the Health Insurance Portability and Accountability Act.
This document really gets to the critical issue behind implementing a point-of-care test.
Full hybridization[4,5] of diagnostic testing cannot be achieved without "information capture" from devices and enterprise-wide assimilation of point-of-care test results, including data from ex vivo and in vivo devices used in neonatology and critical care.
Although point-of-care test sites are by definition remote from the central laboratory and are not staffed by laboratorians, lab personnel tend to be blamed for errors related to testing and test results.
Food and Drug Administration ("FDA") approved and CLIA (Clinical Laboratory Improvements Amendments Act of 1988) waived rapid point-of-care test that can detect antibodies to both HIV-1 and HIV-2 in 20 minutes, using oral fluid, finger-stick or venipuncture whole blood and plasma specimens.
A point-of-care test panel that makes it easier for physicians to test PSA and other related markers and to track PSA velocity, or changes over time, will allow doctors and patients to make critical treatment decisions, increase the efficiency of the office visit, address patient anxiety and ultimately lead to better patient care and management of this disease.